Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 1, 2006, Pages 39-42

  Von Delius, Stefan ^a   Lersch, C ^a   Schulte Frohlinde, E ^a   Fend, F ^a   Dobritz, M ^a   Schmid, R M ^a   Eckel, F ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hemochromatosis; Hepatocellular carcinoma; Iron overload; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CAPECITABINE; CHOLINESTERASE; FERRITIN; IMATINIB; TRANSFERRIN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PERITONEUM METASTASIS; PHLEBOTOMY; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HEMOCHROMATOSIS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE;

EID: 31944450208     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858567     Document Type: Article

References (35)

1. Kew MC. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks. Gastroenterology 1989; 97: 136-139
2. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4: 136-146
3. Cauza E, Peck-Radosavljevic M, Ulrich-Pur H et al. Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol 2003; 98: 442-447
4. Niederau C, Fischer R, Sonnenberg A et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-1262
5. Elmberg M, Hultcrantz R, Ekbom A et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003; 125: 1733-1741
6. Hsing AW, McLaughlin JK, Olsen JH et al. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995; 60: 160-162
7. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408
8. Carella M, D'Ambrosio L, Totaro A et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-832
9. Nielsen P, Carpinteiro S, Fischer R et al. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol 1998; 103: 842-845
10. Merryweather-Clarke AT, Pointon JJ, Shearman JD et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-278
11. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350: 2283-2297
12. Beutler E, Felitti V, Gelbart T et al. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133: 329-337
13. Koziol JA, Felitti VJ, Beutler E. The effect of HFE genotypes on measurements of iron overload. Ann Intern Med 2002; 137: 700-701
14. Guyader D, Gandon Y, Deugnier Y et al. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989; 97: 737-743
15. Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994; 356: 293-302
16. Fargion S, Mandelli C, Piperno A et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655-659
17. Niederau C, Fischer R, Purschel A et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119
18. Blumberg RS, Chopra S, Ibrahim R et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 1988; 95: 1399-1402
19. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362 (9399): 1907-1917
20. Fracanzani AL, Conte D, Fraquelli M et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001; 33: 647-651
21. Britto MR, Thomas LA, Balaratnam N et al. Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis. Scand J Gastroenterol 2000; 35: 889-893
22. Deugnier YM, Guyader D, Crantock L et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993; 104: 228-234
23. Goh J, Callagy G, McEntee G et al. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. Eur J Gastroenterol Hepatol 1999; 11: 915-919
24. Brage A, Tome S, Figueruela B et al. Hepatoma in a 40-year old male with hereditary hemochromatosis in the absence of cirrhosis. Implications of molecular diagnosis. Rev Esp Enferm Dig 2002; 94: 493-499
25. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 1997; 23: 783-792
26. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993; 57 (5 Suppl): 779-786
27. Hann HW, Stahlhut MW, Hann CL. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 1990; 11: 566-569
28. Rothenberg BE, Voland JR. Beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 1996; 93: 1529-1534
29. Chapoutot C, Esslimani M, Joomaye Z et al. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 2000; 46: 711-714
30. Ganne-Carrie N, Christidis C, Chastang C et al. Liver iron is predictive of death in alcoholic cirrhosis: A multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut 2000; 46: 277-282
31. Tavill A. Diagnosis and management of hemochromatosis. Hepatology 2001; 33: 1321-1328
32. Pleass H, Garden OJ. Early diagnosis of hepatocellular carcinoma in hemochromatosis influences surgical management. Scot Med J 1998; 43: 114-115
33. Muting D, Kalk JF, Fischer R et al. Spontaneous regression of oesophageal varices after long-term conservative treatment: Retrospective study in 20 patients with alcoholic liver cirrhosis, post-hepatitic cirrhosis and haemochromatosis with cirrhosis. J Hepatol 1990; 10: 158-162
34. Ioannou GN, Kowdley KV. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen? Clin Gastroenterol Hepatol 2003; 1: 246-248
35. Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004; 127: 79-86